Piotr Podolec Selected Research

Percutaneous Coronary Intervention

1/2015	Myocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf 'unlimited' therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study.
3/2013	Infarct size determines myocardial uptake of CD34+ cells in the peri-infarct zone: results from a study of (99m)Tc-extametazime-labeled cell visualization integrated with cardiac magnetic resonance infarct imaging.
1/2011	Increased prevalence of cardiovascular risk factors in patients with acute coronary syndrome and indications for treatment with oral anticoagulation.
1/2008	Predictive factors of myocardial reperfusion in patients with anterior wall acute myocardial infarction.
4/2004	Mitral regurgitation before and after percutaneous coronary interventions.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Piotr Podolec Research Topics

Disease

17	Fibrosis (Cirrhosis) 01/2023 - 12/2016
13	Heart Failure 01/2023 - 01/2004
13	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 02/2002
12	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2022 - 12/2016
9	Atherosclerosis 01/2022 - 01/2002
9	Inflammation (Inflammations) 01/2022 - 11/2003
9	Hypertension (High Blood Pressure) 01/2021 - 01/2011
8	Atrial Fibrillation 01/2021 - 01/2002
8	Atrial Heart Septal Defects (Atrial Septal Defect) 05/2018 - 01/2004
7	Pulmonary Hypertension 01/2022 - 01/2004
7	Stroke (Strokes) 01/2022 - 04/2009
7	Cardiovascular Diseases (Cardiovascular Disease) 03/2021 - 05/2007
7	Pathologic Constriction (Stenosis) 08/2016 - 01/2002
6	Acute Coronary Syndrome 01/2021 - 01/2011
5	Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy) 01/2023 - 01/2008
5	Infarction (Infarctions) 12/2022 - 10/2004
5	Pulmonary Arterial Hypertension 01/2020 - 11/2012
5	Myocardial Infarction 01/2017 - 10/2004
4	Endocarditis 01/2023 - 01/2020
4	Aortic Valve Stenosis (Aortic Stenosis) 07/2004 - 01/2002
3	Fabry Disease (Fabry's Disease) 03/2024 - 01/2021
3	Pulmonary Embolism 01/2023 - 01/2021
3	Diabetes Mellitus 01/2022 - 08/2016
3	Thromboembolism 01/2022 - 04/2014
3	Left Ventricular Dysfunction 09/2021 - 01/2011
3	Infections 01/2020 - 02/2003
3	Carotid Stenosis (Carotid Artery Stenosis) 07/2019 - 07/2013
3	Familial Primary Pulmonary Hypertension 01/2019 - 03/2017
3	Neoplasms (Cancer) 06/2017 - 12/2016
3	Heart Diseases (Heart Disease) 11/2016 - 01/2012
3	Thrombosis (Thrombus) 04/2014 - 01/2012
3	Ischemic Stroke 12/2009 - 04/2009
3	Pain (Aches) 01/2008 - 09/2004
3	Mitral Valve Insufficiency (Mitral Regurgitation) 07/2004 - 01/2002
2	Cardiomyopathies (Cardiomyopathy) 01/2023 - 02/2003
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2022 - 07/2011
2	Bradycardia 01/2021 - 01/2012
2	Overweight 01/2021 - 01/2015
2	Hemorrhage 01/2021 - 10/2019
2	Bundle-Branch Block (Fascicular Block) 10/2020 - 01/2002
2	Aortic Coarctation 12/2019 - 05/2018
2	Congenital Heart Defects (Congenital Heart Defect) 01/2019 - 02/2015
2	Univentricular Heart 05/2018 - 10/2017

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2011
7	CollagenIBA 01/2022 - 11/2003
7	CalciumIBA 11/2016 - 01/2002
6	GadoliniumIBA 02/2022 - 01/2008
6	LDL CholesterolIBA 08/2018 - 01/2002
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022 - 01/2004
5	MicroRNAs (MicroRNA)IBA 01/2022 - 03/2017
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2014
5	procollagen type I carboxy terminal peptide (PICP)IBA 01/2020 - 12/2016
5	Connective Tissue Growth FactorIBA 01/2020 - 12/2016
5	procollagen Type III-N-terminal peptide (PIIP)IBA 01/2020 - 12/2016
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023 - 01/2017
4	pro-brain natriuretic peptide (1-76)IBA 01/2023 - 01/2011
4	Collagen Type I (Type I Collagen)IBA 01/2020 - 12/2016
4	Peptides (Polypeptides)IBA 03/2018 - 12/2016
4	Creatine Kinase (Creatine Phosphokinase)IBA 08/2009 - 09/2004
3	OximesIBA 01/2023 - 01/2020
3	Troponin T (Troponin T1)IBA 01/2023 - 01/2015
3	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2023 - 05/2018
3	Galectin 3 (LGALS3)IBA 01/2023 - 01/2020
3	Immunoglobulin G (IgG)IBA 01/2022 - 02/2003
3	Antiphospholipid AntibodiesIBA 01/2022 - 11/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 01/2011
3	C-Reactive ProteinIBA 01/2022 - 01/2011
3	lipoprotein cholesterolIBA 01/2021 - 01/2018
3	FibrinIBA 01/2020 - 04/2009
3	Thrombin FDA Link 01/2020 - 03/2005
3	Fibrinogen (Factor I)FDA Link 12/2019 - 01/2002
3	CholesterolIBA 12/2019 - 01/2011
3	LipidsIBA 01/2019 - 01/2002
3	CytokinesIBA 01/2019 - 01/2011
3	Matrix Metalloproteinases (MMPs)IBA 03/2018 - 12/2016
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2017 - 12/2016
3	Endothelin-1 (Endothelin 1)IBA 08/2014 - 01/2004
3	Phosphotransferases (Kinase)IBA 01/2008 - 09/2004
2	GalactosidasesIBA 01/2024 - 01/2021
2	EnzymesIBA 01/2024 - 12/2016
2	Trinitrotoluene (TNT)IBA 01/2023 - 01/2021
2	Indicators and Reagents (Reagents)IBA 01/2021 - 11/2014
2	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 01/2013
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2020 - 01/2017
2	Neprilysin (Neutral Endopeptidase)IBA 11/2020 - 01/2017
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 03/2018
2	AnticoagulantsIBA 01/2019 - 01/2018
2	Procollagen Type IIBA 03/2018 - 12/2016

Therapy/Procedure

16	Therapeutics 03/2024 - 01/2006
7	Myocardial Revascularization 01/2021 - 01/2015
6	Catheters 01/2023 - 02/2012
6	Fontan Procedure (Fontan Operation) 01/2019 - 04/2014
6	Septal Occluder Device 12/2009 - 01/2004
5	Stents 01/2022 - 01/2012
5	Secondary Prevention 12/2020 - 01/2013
5	Percutaneous Coronary Intervention 01/2015 - 04/2004
5	Heart Transplantation (Grafting, Heart) 01/2006 - 01/2002
4	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2021 - 12/2010
3	Endarterectomy (Thromboendarterectomy) 01/2022 - 08/2016
3	Contraindications 01/2020 - 01/2006